Israel’s UroGen Pharma (see here previously) has published positive results from two clinical trials of bladder cancer treatment UGN-102. The therapy can benefit some 80,000 patients. Trial success (65%) was similar to patients who had surgery but with a 55% less re-occurrence rate.

https://en.globes.co.il/en/article-urogen-to-raise-120m-after-positive-bladder-cancer-trial-results-1001453726